| BID regulation by p53 contributes to chemosensitivity JK Sax, P Fei, ME Murphy, E Bernhard, SJ Korsmeyer, WS El-Deiry Nature cell biology 4 (11), 842-849, 2002 | 580 | 2002 |
| Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth P Fei, W Wang, S Kim, S Wang, TF Burns, JK Sax, M Buzzai, DT Dicker, ... Cancer cell 6 (6), 597-609, 2004 | 268 | 2004 |
| Behaviour of house mice artificially selected for high levels of voluntary wheel running P Koteja, T Garland Jr, JK Sax, JG Swallow, PA Carter Animal behaviour 58 (6), 1307-1318, 1999 | 166 | 1999 |
| p53 downstream targets and chemosensitivity. JK Sax, WS El-Deiry Cell Death & Differentiation 10 (4), 2003 | 148 | 2003 |
| Biophysical and functional characterization of full-length, recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherichia coli: comparison of wild … PT Wingfield, JK Sax, SJ Stahl, J Kaufman, I Palmer, V Chung, ... Journal of Biological Chemistry 274 (30), 21362-21368, 1999 | 128 | 1999 |
| Identification and characterization of the cytoplasmic protein TRAF4 as a p53-regulated proapoptotic gene JK Sax, WS El-Deiry Journal of Biological Chemistry 278 (38), 36435-36444, 2003 | 73 | 2003 |
| Dietary supplements are not all safe and not all food: how the low cost of dietary supplements preys on the consumer JK Sax American Journal of Law & Medicine 41 (2-3), 374-394, 2015 | 46 | 2015 |
| Ending event-based regulation of GMO crops SH Strauss, JK Sax Nature Biotechnology 34 (5), 474-477, 2016 | 45 | 2016 |
| Food labeling and consumer associations with health, safety, and environment JK Sax, N Doran The Journal of Law, Medicine & Ethics 44 (4), 630-638, 2016 | 35 | 2016 |
| The cyclin-dependent kinase inhibitor butyrolactone is a potent inhibitor of p21 (WAF1/CIP1 expression). JK Sax, BC Dash, R Hong, DT Dicker, WS El-Deiry Cell Cycle (Georgetown, Tex.) 1 (1), 90-96, 2002 | 31 | 2002 |
| Microarray expression profiling of p53-dependent transcriptional changes in an immortalized mouse embryo fibroblast cell line JK Sax, A Stoddard, ME Murphy, L Chodosh, WS El-Deiry Cancer biology & therapy 2 (4), 416-430, 2003 | 22 | 2003 |
| Financial conflicts of interest in science JK Sax Annals Health L. 21, 291, 2012 | 21 | 2012 |
| Biotechnology and consumer decision-making JK Sax Seton Hall L. Rev. 47, 433, 2016 | 18 | 2016 |
| The States Race with the Federal Government for Stem Cell Research JK Sax Annals Health L. 15, 1, 2006 | 14 | 2006 |
| Administrative guidance and genetically modified food EL Rubin, JK Sax Ariz. L. Rev. 60, 539, 2018 | 13 | 2018 |
| Protecting Scientific Integrity: The Commercial Speech Doctrine Applied to Industry Publications JK Sax American journal of law & medicine 37 (2-3), 203-224, 2011 | 12 | 2011 |
| p53-Induced Gene Expression Analysis JK Sax, WS El-Deiry p53 Protocols, 65-71, 2003 | 12 | 2003 |
| Ambiguity and consumer perceptions of risk in various areas of biotechnology JK Sax, N Doran Journal of consumer policy 42, 47-58, 2019 | 11 | 2019 |
| The separation of politics and science J Sax | 10 | 2013 |
| Reforming FDA Policy for Pediatric Testing: Challenges and Changes in the Wake of Studies Using Antidepressant Drugs JK Sax Ind. Health L. Rev. 4, 61, 2007 | 9 | 2007 |
